FDA “Follow-On” Biologics Guidance: A Preview

[CDER Acting Director Galson discussed FDA's upcoming guidance on "follow on" biologics during the Schwab Washington Research Group health care conference May 5. Here is a transcript of his remarks, by "The Pink Sheet".]